By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:




Affinimark Technologies Inc. 

Company News
Biocryst (BCRX) Reports Second Quarter 2017 Financial Results 8/7/2017 11:09:47 AM
Biocryst (BCRX) Announces Initiation Of ZENITH-1, A Clinical Trial To Evaluate BCX7353 As An Acute Treatment Of Hereditary Angioedema Attacks 8/2/2017 9:48:57 AM
Biocryst (BCRX) To Announce Second Quarter 2017 Financial Results On August 7 7/24/2017 9:47:16 AM
Biocryst (BCRX) Announces RAPIVAB Pediatric sNDA Acceptance 6/5/2017 10:05:21 AM
Robert A. Ingram Named Chairman Of Biocryst (BCRX) 5/30/2017 8:14:25 AM
Biocryst (BCRX) Stock Caught Fire After Reporting Positive Phase II HAE Data 5/26/2017 5:59:48 AM
Biocryst (BCRX) Reports First Quarter 2017 Financial Results 5/4/2017 11:50:46 AM
Biocryst (BCRX) To Announce First Quarter 2017 Financial Results May 4 4/25/2017 9:51:28 AM
Biocryst (BCRX) Expands Development Of BCX7353 To Explore Treatment Of Acute HAE Attacks 4/12/2017 10:26:12 AM
Biocryst (BCRX) Prices Public Offering Of Common Stock 3/10/2017 10:02:10 AM